Home
Subscriber Services
Archives
Media Kit
About Us
Contact Us
Home
Subscriber Services
Archives
Media Kit
About Us
Contact Us
Cover Stories
Cover Story
Column
Channels
Executive Advice
Healthcare Facility
Healthcare Products
Pharmaceutical
Marketing Services
DIGITAL EDITION
CURRENT ISSUE
DIGITAL ARCHIVES
Login
Lost Password?
Web Archive
June, 2008
April, 2008
January, 2008
July, 2007
January, 2006
August, 2005
July, 2005
January, 2005
Does the Recent Glaxo Consent Decree Indicate a Shift at FDA?
Sunday, 31 July 2005
Lancaster Laboratories provides commercial testing and onsite staff.
Trade Ya: Why Business Bartering Makes Sense
Sunday, 31 July 2005
FDA has issued a final guidance titled "Pharmacogenomic Data Submissions" in order to speed the development of new medical products.
FDA Puts 'Personalized Medicine' On Fast Track
Sunday, 31 July 2005
FDA has issued a final guidance titled "Pharmacogenomic Data Submissions" in order to speed the development of new medical products.
Lancaster Continues Growth
By Kirsten Srinivasan
Sunday, 31 July 2005
Lancaster Laboratories provides commercial testing and onsite staff.